Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Nanoviricides Inc (NNVC)

4.65   -1 (-17.7%) 03-05 08:38
Open: 5.4 Pre. Close: 5.65
High: 5.47 Low: 4.46
Volume: 1,430,080 Market Cap: 50M
NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. The company is headquartered in Shelton, Connecticut and currently employs 17 full-time employees. The firm is a development-stage company with several drugs in various stages of development. The firm focuses on its research and clinical programs on specific anti-viral therapeutics. The firm is engaged in the application of nanomedicine technologies to the issues of viral diseases. The firm's nanoviricide technology enables direct attacks at multiple points on a virus particle. In addition, the nanoviricide technology also simultaneously enables attacking the intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The nanoviricide technology is engaged in both attacking extracellular virus thereby breaking the reinfection cycle, and simultaneously disrupting intracellular production of the virus, thereby enabling complete control of a virus infection.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.476 - 5.506 5.506 - 5.53
Low: 4.399 - 4.43 4.43 - 4.456
Close: 4.601 - 4.651 4.651 - 4.692

Technical analysis

as of: 2021-03-05 8:14:08 AM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 7.95     One year: 10.17
Support: Support1: 3.73    Support2: 3.10
Resistance: Resistance1: 6.81    Resistance2: 8.71
Pivot: 4.91
Moving Average: MA(5): 5.07     MA(20): 4.92
MA(100): 3.90     MA(250): 5.26
MACD: MACD(12,26): 0.23     Signal(9): 0.23
Stochastic oscillator: %K(14,3): 36.91     %D(3): 34.94
RSI: RSI(14): 49.82
52-week: High: 12.20  Low: 2.85  Change(%): -58.4
Average Vol(K): 3-Month: 260792  10-Days: 1374332

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
NNVC has closed above bottom band by 40.1%. Bollinger Bands are 187.9% wider than normal. The large width of the bands suggest high volatility as compared to NNVC's normal range. The bands have been in this wide range for 28 bars. This is a sign that the current trend might continue.

Headline News

Thu, 04 Mar 2021
Should You Sell NanoViricides Inc (NNVC) Stock Thursday Morning? - InvestorsObserver

Wed, 03 Mar 2021
NNVC Stock Price Increased 57.58%: Why It Happened - Pulse 2.0

Tue, 02 Mar 2021
Nanoviricides shares are trading higher after the company reported on the - Benzinga

Tue, 02 Mar 2021
45 Stocks Moving In Tuesday's Mid-Day Session Benzinga - Benzinga

Tue, 02 Mar 2021
NanoViricides, Inc. Pan-coronavirus Clinical Drug Candidates for the Treatment of COVID-19 Are Highly Effective in Pre-clinical Cell Culture Studies Performed in Preparation of FDA Pre-IND Application - Yahoo Finance

Thu, 18 Feb 2021
We're Hopeful That NanoViricides (NYSEMKT:NNVC) Will Use Its Cash Wisely - Yahoo Finance

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 11
Shares Float (M) 6
% Held by Insiders 14.97
% Held by Institutions 19.66
Shares Short (K) 634
Shares Short P. Month (K) 689

Stock Financials

EPS -3.106
EPS Est This Year -0.200
EPS Est Next Year 0.040
Book Value (p.s.) 1.870
Profit Margin
Operating Margin
Return on Assets (ttm) -32.6
Return on Equity (ttm) -102.0
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.716
Qtrly Earnings Growth
Operating Cash Flow (M) -7
Levered Free Cash Flow (M) -4

Stock Valuations

PE Ratio -1.50
PEG Ratio
Price to Book value 2.49
Price to Sales
Price to Cash Flow -7.31

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.